The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies. Consistent benefit across multiple exacerbation endpoints

MeiLan K. Han; Gerard Criner; Mark Dransfield; David Halpin; C. Elaine Jones; Sally Kilbride; Peter Lange; David Lomas; Fernando Martinez; Holly Quasny; David Singh; Robert Wise; David Lipson

doi:10.1183/13993003.congress-2019.PA2483

The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies. Consistent benefit across multiple exacerbation endpoints

MeiLan K. Han, Gerard Criner, Mark Dransfield, David Halpin, C. Elaine Jones, Sally Kilbride, Peter Lange, David Lomas, Fernando Martinez, Holly Quasny, David Singh, Robert Wise, David Lipson

Afdeling for Epidemiologi

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	PA2483
Tidsskrift	European Respiratory Journal
Vol/bind	54
Udgave nummer	Supplement 63
ISSN	0903-1936
DOI	https://doi.org/10.1183/13993003.congress-2019.PA2483
Status	Udgivet - 2019

Adgang til dokumentet

10.1183/13993003.congress-2019.PA2483

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Han, M. K., Criner, G., Dransfield, M., Halpin, D., Jones, C. E., Kilbride, S., Lange, P., Lomas, D., Martinez, F., Quasny, H., Singh, D., Wise, R., & Lipson, D. (2019). The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies. Consistent benefit across multiple exacerbation endpoints. European Respiratory Journal, 54(Supplement 63), Artikel PA2483. https://doi.org/10.1183/13993003.congress-2019.PA2483

Han, MK, Criner, G, Dransfield, M, Halpin, D, Jones, CE, Kilbride, S, Lange, P, Lomas, D, Martinez, F, Quasny, H, Singh, D, Wise, R & Lipson, D 2019, 'The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies. Consistent benefit across multiple exacerbation endpoints', European Respiratory Journal, bind 54, nr. Supplement 63, PA2483. https://doi.org/10.1183/13993003.congress-2019.PA2483

@article{91d39a9c15bb495ca9c3b1206ba1563c,

title = "The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies. Consistent benefit across multiple exacerbation endpoints",

keywords = "COPD - exacerbations, COPD - management",

author = "Han, {MeiLan K.} and Gerard Criner and Mark Dransfield and David Halpin and Jones, {C. Elaine} and Sally Kilbride and Peter Lange and David Lomas and Fernando Martinez and Holly Quasny and David Singh and Robert Wise and David Lipson",

year = "2019",

doi = "10.1183/13993003.congress-2019.PA2483",

language = "English",

volume = "54",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "Supplement 63",

}

TY - ABST

T1 - The IMPACT Trial

T2 - Single Inhaler Triple Therapy vs dual therapies. Consistent benefit across multiple exacerbation endpoints

AU - Han, MeiLan K.

AU - Criner, Gerard

AU - Dransfield, Mark

AU - Halpin, David

AU - Jones, C. Elaine

AU - Kilbride, Sally

AU - Lange, Peter

AU - Lomas, David

AU - Martinez, Fernando

AU - Quasny, Holly

AU - Singh, David

AU - Wise, Robert

AU - Lipson, David

PY - 2019

Y1 - 2019

KW - COPD - exacerbations

KW - COPD - management

U2 - 10.1183/13993003.congress-2019.PA2483

DO - 10.1183/13993003.congress-2019.PA2483

M3 - Conference abstract in journal

SN - 0903-1936

VL - 54

JO - European Respiratory Journal

JF - European Respiratory Journal

IS - Supplement 63

M1 - PA2483

ER -